EP4028423 - ANTI-PD-L1 SINGLE-DOMAIN ANTIBODY AND DERIVATIVES AND USE THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 17.06.2022 Database last updated on 13.12.2024 | |
Former | The international publication has been made Status updated on 20.03.2021 | Most recent event Tooltip | 27.09.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Biotheus Inc. 10B, Building 4 N°1 Keji 7th Road Tangjiawan Town, Xiangzhou District Zhuhai, Guangdong 519080 / CN | [2022/29] | Inventor(s) | 01 /
XU, Yifeng 10B, Building 4, No 1 Keji 7th Road, Tangjiawan Town, Xiangzhou District Zhuhai, Guangdong 519080 / CN | 02 /
ZHAI, Tianhang 10B, Building 4, No 1 Keji 7th Road, Tangjiawan Town, Xiangzhou District Zhuhai, Guangdong 519080 / CN | 03 /
YUAN, Zhijun 10B, Building 4, No 1 Keji 7th Road, Tangjiawan Town, Xiangzhou District Zhuhai, Guangdong 519080 / CN | 04 /
TSUN, Andy 10B, Building 4, No 1 Keji 7th Road, Tangjiawan Town, Xiangzhou District Zhuhai, Guangdong 519080 / CN | 05 /
SUN, Tsoyue Joanne 10B, Building 4, No 1 Keji 7th Road, Tangjiawan Town, Xiangzhou District Zhuhai, Guangdong 519080 / CN | 06 /
HUANG, Weifeng 10B, Building 4, No 1 Keji 7th Road, Tangjiawan Town, Xiangzhou District Zhuhai, Guangdong 519080 / CN | [2022/29] | Representative(s) | Cabinet Nony 11 rue Saint-Georges 75009 Paris / FR | [N/P] |
Former [2022/29] | Nony 11 rue Saint-Georges 75009 Paris / FR | Application number, filing date | 20863990.6 | 07.09.2020 | [2022/29] | WO2020IB58303 | Priority number, date | CN201910863109 | 12.09.2019 Original published format: CN201910863109 | [2022/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021048725 | Date: | 18.03.2021 | Language: | EN | [2021/11] | Type: | A1 Application with search report | No.: | EP4028423 | Date: | 20.07.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.03.2021 takes the place of the publication of the European patent application. | [2022/29] | Search report(s) | International search report - published on: | CN | 18.03.2021 | (Supplementary) European search report - dispatched on: | EP | 21.08.2023 | Classification | IPC: | C07K16/28, A61K39/395, C12N15/13, A61P35/00 | [2022/29] | CPC: |
A61K47/6849 (EP,KR,US);
C07K16/2827 (EP,CN,KR,US);
A61K47/6811 (EP,KR);
A61P35/00 (EP,CN,KR,US);
A61P35/02 (EP,CN);
A61P35/04 (EP,CN);
C07K14/71 (CN,US);
G01N33/57492 (EP,CN,KR);
G01N33/68 (CN);
A61K2039/505 (EP,CN,US);
A61K38/00 (CN);
C07K2317/34 (EP);
C07K2317/565 (CN,US);
C07K2317/569 (EP,CN,KR,US);
C07K2317/76 (EP,CN,US);
C07K2317/92 (EP,CN,KR,US);
C07K2317/94 (EP,CN,KR);
C07K2319/00 (EP,CN);
C07K2319/30 (CN,US);
C07K2319/32 (EP);
C07K2319/33 (EP);
G01N2333/70532 (EP,CN)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/29] | Title | German: | ANTI-PD-L1-SINGLE-DOMAIN-ANTIKÖRPER UND DERIVATE UND VERWENDUNG DAVON | [2022/29] | English: | ANTI-PD-L1 SINGLE-DOMAIN ANTIBODY AND DERIVATIVES AND USE THEREOF | [2022/29] | French: | ANTICORPS À DOMAINE UNIQUE ANTI-PD-L1, DÉRIVÉS ET UTILISATION ASSOCIÉS | [2022/29] | Entry into regional phase | 11.04.2022 | National basic fee paid | 11.04.2022 | Search fee paid | 11.04.2022 | Designation fee(s) paid | 11.04.2022 | Examination fee paid | Examination procedure | 11.04.2022 | Examination requested [2022/29] | 05.03.2024 | Amendment by applicant (claims and/or description) | 05.03.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 30.09.2022 | Renewal fee patent year 03 | 02.10.2023 | Renewal fee patent year 04 | 25.09.2024 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]CN107849130 (SUZHOU ALPHAMAB CO LTD, et al); | [A]WO2019096121 (NANJING LEGEND BIOTECH CO LTD [CN]); | [A]CN110003333 (SHENZHEN PREGENE BIOPHARMACEUTICAL CO LTD); |